Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:10-Nitrooleic acid)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteUnits(range)
ST002283 AN003728 The “ForensOMICS” approach to forensic post-mortem interval estimation: combining metabolomics, lipidomics and proteomics for the analysis human skeletal remains Bone Human University of Central Lancashire Area integration
ST000257 AN000406 NIH WCMC Pilot & Feasibility Project: ?Metabolite changes associated with weight loss? Adipose tissue Mouse University of California, Davis nM
ST000257 AN000406 NIH WCMC Pilot & Feasibility Project: ?Metabolite changes associated with weight loss? Blood Mouse University of California, Davis nM
ST000257 AN000406 NIH WCMC Pilot & Feasibility Project: ?Metabolite changes associated with weight loss? Brain Mouse University of California, Davis nM
ST000257 AN000406 NIH WCMC Pilot & Feasibility Project: ?Metabolite changes associated with weight loss? Liver Mouse University of California, Davis nM
ST000257 AN000406 NIH WCMC Pilot & Feasibility Project: ?Metabolite changes associated with weight loss? Muscle Mouse University of California, Davis nM
ST000802 AN001274 Insights into myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) phenotypes through comprehensive metabolomics (part III)) Blood Human Myalgic encephalomyelitis/chronic fatigue syndrome University of California, Davis nM
ST000846 AN001369 Statin Immuno-Metabolomics in Asthma (part IV) Lung Rhesus monkey Asthma USDA nM
ST001154 AN001946 A comprehensive plasma metabolomics dataset for a cohort of mouse knockouts within the International Mouse Phenotyping Consortium Blood Mouse University of California nM
ST001245 AN002069 Luteal lipids regulate progesterone production and may modulate immune cell function during the estrous cycle and pregnancy Corpus Luteum Cow University of California, Davis nM
ST001845 AN002988 Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD) (part IV) Blood Human Fatty liver disease University of California, Davis nM
ST002001 AN003264 A case-control study on plasma metabolomics analysis in Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) (Part 2) Blood Human Myalgic encephalomyelitis/chronic fatigue syndrome Columbia University nM
ST002767 AN004503 Metabolomic analysis of maternal mid-gestation plasma and cord blood: oxylipins Blood Human Autism Columbia University nM
ST002800 AN004556 Hepatic oxylipin profiles in mouse models of Wilson disease: new insights into early hepatic manifestations. Liver Mouse Wilson disease University of California, Davis nM
ST002977 AN004887 Offline Two-dimensional Liquid Chromatography-Mass Spectrometry for Deep Annotation of the Fecal Metabolome following Fecal Microbiota Transplant Feces Human University of Michigan Peak area
ST002977 AN004890 Offline Two-dimensional Liquid Chromatography-Mass Spectrometry for Deep Annotation of the Fecal Metabolome following Fecal Microbiota Transplant Feces Human University of Michigan Peak area
ST000594 AN000910 PGD2 and other lipid mediator changes in mouse adipose associated with administration of an oral inhibitor of H-PGDS (HQL-79) (part II) Adipose tissue Mouse Obesity USDA Western Human Nutrition Research Center pmol/g
ST000598 AN000916 Dysfunctional lipid metabolism underlies the effect of the perinatal DDT exposure on the development of metabolic syndrome (part II) Brain Mouse Metabolic syndrome USDA Western Human Nutrition Research Center pmol/g
ST000659 AN001006 Changes in metabolites and lipid mediators associated with supervised exercise training for peripheral Blood Human Peripheral artery disease USDA Western Human Nutrition Research Center pmol/g
ST000977 AN001598 Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD) Blood Human Fatty liver disease University of California, Davis pmol/gram
ST002094 AN003421 Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) Feces Human Irritable bowel syndrome Mayo Clinic raw intensity
  logo